American Journal of Cardiology
Volume 104, Issue 11 , Pages 1457-1464, 1 December 2009

Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)

  • Xue-Qiao Zhao, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, University of Washington School of Medicine, Seattle, Washington
    • Corresponding Author InformationCorresponding author: Tel: 206-616-4905; fax: 206-616-4667
    • ,
  • Richard A. Krasuski, MD

      Affiliations

    • Department of Cardiology, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Jefferson Baer, MD

      Affiliations

    • Department of Cardiology, Emory University, Atlanta, Georgia
    • ,
  • Edwin J. Whitney, MD

      Affiliations

    • Heart Vascular Institute of Texas, San Antonio, Texas
    • ,
  • Blazej Neradilek, MS

      Affiliations

    • Mountain-Whisper-Light Statistical Consulting, Seattle, Washington
    • ,
  • Alan Chait, MD

      Affiliations

    • Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington
    • ,
  • Santica Marcovina, PhD, ScD

      Affiliations

    • Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington
    • ,
  • John J. Albers, PhD

      Affiliations

    • Division of Metabolism, Endocrinology, and Nutrition, University of Washington School of Medicine, Seattle, Washington
    • ,
  • B. Greg Brown, MD, PhD

      Affiliations

    • Department of Medicine, Division of Cardiology, University of Washington School of Medicine, Seattle, Washington

Received 28 February 2009; received in revised form 2 July 2009; accepted 2 July 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The Familial Atherosclerosis Treatment Study was supported by Grants P01 HL30086 and R01 HL19451 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. The HDL-Atherosclerosis Treatment Study was supported in part by Grant R01 HL49546 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland and the 2 studies were supported with National Institutes of Health funding through the Clinical Nutrition Research Unit (DK 35816) and the Diabetes Endocrinology Research Center (DK 17047) at the University of Washington, Seattle, Washington. The Armed Forces Regression Study was supported by an unrestricted grant from the former Parke Davis Branch of Pfizer, Inc., New York, New York.

PII: S0002-9149(09)01353-8

doi:10.1016/j.amjcard.2009.07.035

American Journal of Cardiology
Volume 104, Issue 11 , Pages 1457-1464, 1 December 2009

Article Tools

* Image Usage & Resolution